Bristol-Myers Squibb Co (NYSE:BMY)
| 59.26 Delayed Data As of Sep 18 |  -0.14 / -0.24%Today’s Change | 45.76 Today|||52-Week Range 68.34 | -7.68% Year-to-Date |
Latest BMY News | Press Releases
Today’s Trading
| Previous close | 59.40 |
| Today’s open | 59.06 |
| Day’s range | 58.84 - 59.72 |
| Volume | 13,944,502 |
| Average volume (3 months) | 12,636,076 |
| Market cap | $133.6B |
Data as of 4:19pm ET, 09/18/2020
Growth & Valuation
| Earnings growth (last year) | -33.05% |
| Earnings growth (this year) | +33.81% |
| Earnings growth (next 5 years) | +12.00% |
| Revenue growth (last year) | +15.89% |
| P/E ratio | NM |
| Price/Sales | 4.20 |
| Price/Book | 2.56 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SNYSanofi | +0.37 | +0.71% |
| NVONovo Nordisk | -0.11 | -0.16% |
| LLYEli Lilly and Co | +1.64 | +1.08% |
| AZNAstraZeneca | +0.51 | +0.91% |
Data as of 4:19pm ET, 09/18/2020
Financials
| Next reporting date | October 22, 2020 |
| EPS forecast (this quarter) | $1.49 |
| Annual revenue (last year) | $26.1B |
| Annual profit (last year) | $3.4B |
| Net profit margin | 13.15% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
